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Abstract We previously demonstrated that spare respira-
tory capacity of the TCA cycle enzyme alpha-ketoglutarate
dehydrogenase (KGDH) was completely abolished upon
increasing levels of MAO-B activity in a dopaminergic cell
modelsystem(Kumaretal.,JBiolChem278:46432–46439,
2003). MAO-Bmediated increases in H2O2also appearedto
result in direct oxidative inhibition of both mitochondrial
complex I and aconitase. In order to elucidate the contri-
bution that each of these components exerts over metabolic
respiratory control as well as the impact of MAO-B eleva-
tion on their spare respiratory capacities, we performed
metabolic respiratory control analysis. In addition to
KGDH, we assessed the activities and substrate-mediated
respiration of complex I, pyruvate dehydrogenase (PDH),
succinate dehydrogenase (SDH), and mitochondrial aconi-
tase in the absence and presence of complex-speciﬁc
inhibitors in speciﬁc and mixed substrate conditions in
mitochondria from our MAO-B elevated cells versus con-
trols. Data from this study indicates that Complex I and
KGDH are the most sensitive to inhibition by MAO-B
mediated H2O2 generation, and could be instrumental in
determining the fate of mitochondrial metabolism in this
cellular PD model system.
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Introduction
Mitochondrial dysfunction due to impaired oxidative
phosphorylation has been implicated as a major factor in
the pathogenesis of several neurodegenerative disorders. It
has, for example, been associated with defects in various
mitochondrial respiratory chain or related complexes in
Parkinson’s disease (PD), Alzheimer’s disease (AD),
Huntington’s disease (HD), and Friedreich’s ataxia (Scha-
pira 1999). Reductions in activities of both mitochondrial
complex I(CI) (Schapira et al. 1989, 1990) and the TCA
cycle enzyme alpha-ketoglutarate dehydrogenase (KGDH)
(Mizuno et al. 1994) which provides substrate for the
complex are in fact physiological hallmarks associated
with human PD neuropathology.
Elevations in the catecholamine-oxidizing enzyme
monoamine oxidase-B (MAO-B) have been suggested to
contribute to PD neuropathology (Cohen and Kesler 1999).
Substrate oxidation by the enzyme is accompanied stoi-
chiometrically by the reduction of oxygen to H2O2 which
in turn can lead to cellular damage (Vindis et al. 2001;
Cohen et al. 1997). We previously demonstrated that subtle
increases in MAO-B levels mimicking those which occur
with age in a genetically engineered dopaminergic PC12
cell line resulted in increased H2O2 production and selec-
tive decreases in the activities of both CI and KGDH
(Kumar et al. 2003). MAO-B elevation was found to
abolish the spare KGDH threshold capacity that normally
requires signiﬁcant inhibition before affecting maximal
mitochondrial oxygen consumption rates. This in turn was
found to compromise the ability of dopaminergic neurons
to cope with increased energetic stress.
Various additional metabolic pathway components may
also be impacted by oxidative stress as a consequence of
MAO-B increase resulting in a cumulative disruptive effect
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of any single component enzyme must be inhibited, how-
ever, to a particular threshold level before it affects
metabolism as a whole (i.e., each enzyme has a ‘reserve
capacity’) (Rossignol et al. 2003). Stress conditions (such
as increased oxidative stress) can change the reserve
capacities of mitochondrial enzymes and, by doing so, may
compromise the cell’s ability to maintain metabolic func-
tion. Here we attempt to more fully characterize the impact
of MAO-B elevation on mitochondrial bioenergetics. We
investigated the respiratory thresholds of several possible
contributors to NADH levels as a substrate for cellular
respiration including the mitochondrial electron transfer
chain enzymes CI and CII (SDH) and the TCA cycle
enzymes aconitase, KGDH, and pyruvate dehydrogenase
(PDH). We measured both basal respiratory thresholds and
losses in spare capacities of these enzymes in the oxidative
stress condition derived from H2O2 generation as a con-
sequence of MAO-B elevation in our model system.
Materials and Methods
All chemicals were obtained from Sigma unless and
otherwise noted.
Doxycycline (dox)-Inducible MAO-B Expressing PC12
Cell Lines
Cell lines expressing MAO-B under transcriptional regula-
tion by doxycycline (dox) (Kumar et al. 2003) were
maintained in DMEM containing 10% FBS, 5% horse
serum, and 1% streptomycin–penicillin in the presence of
200 lg/ml of G418; the cells were neuronally differentiated
via exposure to 50 ng/ml nerve growth factor (NGF) for a
2 day period before addition of dox to induce MAO-B
elevations.
Mitochondrial Preparation
Mitochondria were prepared by homogenizing cells in
mitochondrial medium containing 320 mM sucrose, 5 mM
TES, and 1 mM EGTA, centrifuging the homogenate at
10009g, and pelleting the mitochondria in the resulting
supernatant at 100009g. The mitochondria were resus-
pended in 250 mM sucrose, 10 mM TES, and 0.1% (w/v)
fatty acid free BSA, pH 7.2 for complex I, KGDH, and
citrate synthase assays.
Complex I Activity
Activity was assayed in homogenates from isolated mito-
chondria as rotenone-sensitive NADH dehydrogenase
activity by measuring 2,6-dichlorophenolindophenol
(DCIP) reduction in mitochondrial extract following addi-
tion of 200 lM NADH, 200 lM decylubiquinone, 2 mM
KCN, and 0.002% DCIP in the presence and absence of
2 lM rotenone (Trounce et al. 1996). Values for this and
all subsequent assays were normalized per protein using
BioRad reagent.
KGDH Activity
KGDH activity was assayed as the rate of NAD
?
reduction at 340 nm upon addition of 5.0 mM MgCl2,
40.0 lM rotenone, 2.5 mM a-ketoglutarate, 0.1 mM CoA,
0.2 mM thymine pyrophosphate, and 1.0 mM NAD to
freeze-thawed mitochondria (Nulton-Persson and Szweda
2001). Citrate synthase activity, used to normalize the
mitochondrial load, was measured by assessing the
change in A412 reduction of 2.0 mM DTNB in presence
of 6 mM acetyl CoA and 10 mM oxaloacetate (Trounce
et al. 1996).
Aconitase Activity
Aconitase activity was assayed as the rate of NADP
?
reduction at 340 nm upon addition of 30 mM sodium cit-
rate, 0.6 mM fresh MnCl2, 0.2 mM NADP
?, and 2 U/ml
isocitrate dehydrogenase in 25 mM KH2PO4 pH 7.4,
0.5 mM EDTA to the mitochondrial preparation.
SDH Activity
Succinate dehydrogenase activity was assayed as DCIP
reduction at 600 nm upon addition of 20 mM succinate,
2 mM KCN, 200 lM decylubiquinone, and 0.002% DCIP
in 25 mM KH2PO4 pH 7.4, 0.5 mM EDTA to the mito-
chondria preparation after activation for 15 min at 30Ct o
compete out oxaloacetic acid (OAA) in the presence of
succinate and KCN.
PDH Activity
Pyruvate dehydrogenase was assayed as the reduction of
DTNB at 412 nm by ﬁrst incubating the mitochondrial
preparation in the solution containing 2 mM TPP, 10 mM
DTT and 10 mM sodium pyruvate, 1 mM MgCl2, and
2 mM NAD
?, with or without 0.2 mM sodium Co-A for
15 min at 30C followed by addition of 25 mM OAA and
0.05% DTNB, equilibrating for 10 min, and addition of
5 U/ml citrate synthase. The difference change in absor-
bance over time at 412 nm was recorded in the absence or
presence of sodium Co-A.
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Substrate-speciﬁc respiration was assayed in fresh mito-
chondrial preparations from dox-induced and uninduced
cells in a buffer containing 125 mM KCl, 2 mM KH2PO4,
1 mM MgCl2, and 20 mM HEPES pH 7.0 (Murphy et al.
1996)a t3 0 C using a Clarke electrode (Hansatech). Res-
piration was calculated as the rate of oxygen consumption
using either 5.0 mM pyruvate/5.0 mM malate as substrates
for PDH, 5.0 mM citrate/5.0 mM malate as substrates for
aconitase, 5.0 mM glutamate/5.0 mM malate as substrates
for complex I, or 5.0 mM a-ketoglutarate/5.0 mM malate
as substrates for KGDH in presence or absence of selective
inhibition with 0–100 nM arsenite (KGDH) or 2.0 lM
rotenone (complex I), respectively. FCCP (10 lM) was
added as uncoupler to assess maximum respiration rates.
Inhibitor Titrations
Inhibitor titrations were performed to assess threshold
values and control coefﬁcients. Speciﬁc enzyme inhibitors
used for titration included arsenite/bromopyruvate for
PDH, arsenite alone for KGDH, ﬂuorocitrate for aconitase,
malonate for SDH, and rotenone for complex I-mediated
respiration analyses. To allow maximal contribution of
every component enzyme, respiration was also carried out
using a mixed cocktail of substrates containing 5 mM each
of pyruvate, malate, citrate, a-ketoglutarate, and glutamate
in the presence of speciﬁc separate inhibitors to titrate out
individual enzymes. Since arsenite is not speciﬁc for
KGDH, respiration mediated by KGDH alone was also
assayed in the presence of 20 mM bromopyruvate to
inhibit PDH and its effects. The inhibitor concentrations
used were determined by using close approximations of the
published K. Relative dissociation constants pertinent for
each enzyme were calculated using a derivation of the
Michaelis–Menten equation, Kd = [I]/((Vo/Vi) - 1), where
Vi is the inhibited rate of enzyme, Vo is the initial rate and
[I] is the inhibitor concentration. For our purposes, a Vo
was set at a relative 100% and Vi at a point close but not
equal to zero where the enzyme activity is minimal. Con-
trol coefﬁcients quantitatively describe the control exerted
by each enzyme in a metabolic network over substrate ﬂux
(Cascante et al. 2002). We calculated the control coefﬁ-
cients (Ci) of respiration of the component enzymes using
the equation (Davey et al. 1998):
Ci ¼ð dJ=JÞ=ðd½I =KdÞð 1Þ
where Ci is the control coefﬁcient, dJ is the decrement in
ﬂux, J is the total ﬂux of the substrate, dI is the decrement
in inhibitor concentration, and Kd is the dissociation
constant. To simplify this calculation, we used (dJ/dI),
the initial slope of the titration curve, and J, the uninhibited
respiration rate, at 100% in our relative system (Kunz et al.
1999):
Ci ¼ð dJ=dIÞðKd=JÞð 2Þ
Statistical analysis
Data is expressed as mean ± SD and signiﬁcance testing
was performed using ANOVA.
Results
MAO-B Mediated H2O2 Generation Inhibits
Mitochondrial Enzymes
To study the effects of H2O2 generated by inducible
increases in MAO-B levels on individual respiratory
components in our dopaminergic cell system (Kumar et al.
2003), we measured enzyme activities in mitochondrial
preparations from uninduced versus dox-induced cells
expressing MAO-B in either the absence or presence of the
MAO-B inhibitor deprenyl. MAO-B elevation was found to
substantially inhibit mitochondrial aconitase, KGDH,
complex I, succinate dehydrogenase, and PDH activities to
an extent ranging from 33.5% to nearly 60%; these inhi-
bitions were deprenyl-sensitive (Fig. 1) and prevented by
catalase pretreatment (Kumar et al. 2003) (data not shown
for aconitase, SDH and PDH) suggesting that they were
both MAO-B and H2O2-dependent.
Respiratory Thresholds and Spare Capacities
Speciﬁc inhibitor titrations were initially performed in
order to identify the appropriate inhibitor range to be used
for each enzyme. This inhibitor range was subsequently
used to perform measurements of substrate-speciﬁc respi-
ration. Enzyme inhibition versus respiration was plotted for
each enzyme in order to determine respiratory thresholds
and spare capacities for each in the absence and presence of
MAO-B induction (Fig. 2, Table 1).
Aconitase was found to have a spare capacity of 189%
that is reduced to 89% following MAO-B induction as
indicated by the intercept of the slope at the point of total
respiratory inhibition (Fig. 2a). The threshold value was
determined to be reduced by 19% in MAO-B-expressing
versus control conditions (66% vs. 47%, Table 1).
Complex I was found to have a very low spare capacity
(7%) that was reduced to zero by MAO-B increase
(Fig. 2b). The threshold value of 7.2% in uninduced cells
was reduced to a negative value of 3.37% following MAO-
B induction, a total shift of 10.54 (Table 1). This alteration
was mirrored when respiration was measured using a
substrate mix instead of glutamate/malate alone.
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123SDH and PDH, though vastly different enzyme com-
plexes, behaved in a similar fashion in this study.
Mitochondria have a very high capacity to consume oxy-
gen using speciﬁc substrates for these enzyme complexes;
both enzymes require signiﬁcant inhibition before respira-
tory capacity is diminished (Fig. 2). Though both these
enzymes have sensitivity to hydrogen peroxide as reﬂected
by the MAO-B induced reduction in their speciﬁc activities
(Fig. 1), they appear to have a very high uninduced spare
capacity, 250% and 415%, respectively (Table 1, Fig. 2c,
d). MAO-B elevation reduces this spare capacity only
slightly, from 250% to 196% in the case of SDH and 415%
to 348% in the case of PHD. Threshold values were
determined to be 74% and 82% inhibition, respectively,
which transitioned only slightly following MAO-B
increase (68% and 77%, respectively, Table 1).
For KDGH, we observed a decrease from 57% spare
capacity to 5% under conditions of MAO-B elevation and
the threshold value for inhibition by arsenite was shifted
from 36% to 4.6% under this stress condition (Fig. 2e,
Table 1). Since KGDH is structurally and catalytically
similar to pyruvate PDH and therefore conditions that
inhibit the former may inhibit PDH as well, we also
assessed KDGH inhibition and titration of arsenite-sensi-
tive KGDH dependent respiration in the presence of the
speciﬁc PDH inhibitor, bromopyruvate. In order to mimic
cellular conditions where substrate levels are not limiting,
we used a substrate mixture that included all those speciﬁc
for the enzymes being examined in our studies. Succinate
addition was avoided since SDH displayed an over-
whelming control over respiration masking the
contribution from other components (data not shown).
Similar assessment of effects of titration using other
inhibitors in the presence of a mixed substrate cocktail
without succinate yielded similar results (data not shown).
We found that under conditions in which PDH is inhibited
by bromopyruvate, KDGH had a higher threshold value
(62.8%) which dropped to zero in the presence of MAO-B
increase (Fig. 2f). The threshold of inhibition by arsenite
was found to shift from 38.8% to less than zero in the
presence of up-regulation of MAO-B (Table 1).
Control Coefﬁcients
Flux control analysis (Kacser and Burns 1973, 1979) rep-
resents an approach that can provide important insights into
the functional role of the respiratory chain in various
conditions. If a metabolic pathway is composed of distinct
enzymes, the extent to which each enzyme is rate-con-
trolling may be different and the sum of all the ﬂux control
coefﬁcients for the different enzymes should be equal to
unity (Kacser and Burns 1979; Brand et al. 1994). In our
experiments, the enzymes examined are various contribu-
tors to the ﬁnal end-product, i.e., NADH, which is then
oxidized as substrate by CI thus initiating the mitochon-
drial oxidative phosphorylation cycle. SDH contributes to
this at two levels—ﬁrst during the TCA cycle and later
during ubiquinone reduction. The reactions measured
therefore could be part of a branched pathway and hence
the ﬂux control coefﬁcients could total greater than one
(Cornish-Bowden 2004). In order to acquire an elementary
understanding of relative contributions of the participant
enzymes on total NADH generation in particular and on
oxidative phosphorylation in general, we measured the
relative change in control coefﬁcients between the two
conditions, i.e., the uninduced control and in the presence
of MAO-B mediated H2O2 generation (Table 2). Increased
levels of MAO-B resulted in a shift in the metabolic control
of respiration. Interestingly, CI was found to exert maximal
respiratory control in both basal conditions (ﬂux
Fig. 1 Mitochondrial enzyme
activities are inhibited via
MAO-B elevation. Activities of
the major mitochondrial
enzymes involved in NADH/
FADH production were
measured in mitochondrial
preparations from uninduced
(left bars), dox-induced (middle
bars) and dox-deprenyl co-
treated cells (right bars). n = 5
per condition from three
separate experiments, values are
expressed as mean ± SD,
*P\0.01 compared to no dox
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123Fig. 2 Alterations in respiratory threshold values of NADH-depen-
dent enzymes under conditions of MAO-B-induced stress. Inhibitor
titrations of uncoupled substrate dependent respiration were plotted
against relative inhibition of activity by enzyme-speciﬁc speciﬁc
inhibitors in mitochondria isolated from uninduced control cells
(blue) versus dox-induced cells expressing elevated MAO-B levels
(red). The curves, plotted as trends of the data points shown are:
ﬂuorocitrate inhibition of mitochondrial aconitase (a), rotenone
inhibition of CI (b), malonate inhibition of SDH (c), bromopyruvate
(BrPy) inhibition of PDH (d), arsenite inhibition of KGDH (e), and
arsenite inhibition of KGDH in a background of a total inhibition of
PDH by BrPy (f). Threshold values are calculated as the abscissa at
0% inhibition on the trends drawn at maximal inhibition. The straight
equations represent the respective uninduced (blue) and induced (red)
trends drawn at near total inhibition of uncoupled respiration and
activity by the enzyme-speciﬁc inhibitor. Respiratory spare capacity
is derived by the difference between maximum respiration (100%)
and the ‘y’ intercept of the trend line (at zero inhibition). Dotted
trends and equations at initial points in the curve are used for
calculation of the control coefﬁcients. Actual maximal and minimal
respiration and activity is adjusted to 100 and 0 percent values to
enable comparison and residual inhibitor independent respiration by
the mitochondria has been discounted to facilitate comparative
analysis
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123coefﬁcient, 0.36 and following MAO-B induction (doubled
to 0.65).
Discussion
Investigation of mitochondrial oxidative phosphorylation
usingmetaboliccontrolanalysis(MCA)allowsexamination
of the contribution of various metabolic activities on disease
statesinvolvingmitochondrialdysfunction.Measurementof
theimpactofincreasingconcentrationsofspeciﬁcinhibitors
on enzyme activities versus substrate-speciﬁc respiration is
used to obtain titration curves for graphical determination of
ﬂux control coefﬁcients, an index of each component
enzyme’s contribution to mitochondrial function (Cascante
et al. 2002). Determination of the control coefﬁcients within
a given pathway determines which portion of the pathway is
rate-limiting and can indicate the most efﬁcient point of
intervention. This utility can be exploited to identify key
targets in disease pathways leading to drug discovery. As an
example, moderate effects on the activities of respiratory
chain components upstream and including cytochrome
oxidase (COX) by either inhibitors, mutations or physio-
logical changes can result in dramatic changes in COX
threshold and respiratory control by the enzyme, thereby
affecting a disease phenotype (Villani and Attardi 1997).
Though MCA is probably too simple to account for the
complexity of all disease-related enzymes, it has revealed
the existence of thresholds in terms of enzymatic defects in
oxidative phosphorylation associated with known mito-
chondrial disease mutations that impact on ﬂuxes associated
with enzymatic reserve (Mazat et al. 2001). Disease mani-
festation was found in these cases to only appear when the
activity of a metabolic step had been reduced to a low level.
Threshold effects have been used for the functional deter-
mination of different mitochondrial defects, often by
measuring maximal rates of respiration and the effect of
speciﬁc inhibitors (Davey et al. 1997, 1998; Letellier et al.
1994; Villani et al. 1998; Davey and Clark 1996). The sig-
niﬁcance of alterations in the activities of individual
Table 1 Spare capacities and threshold values
Enzyme % Spare capacity % Threshold value of inhibition
Uninduced Induced Uninduced Induced Reduction
Aconitase 189.03 89.49 66.02 47.48 18.54
aKGDH 57.06 4.95 36.05 4.60 31.45
aKGDH with (BrPy) 62.79 \0 38.76 -4.95 43.71
Complex I 7.30 \0 7.17 -3.37 10.54
SDH 249.47 196.20 73.83 67.91 5.92
PDH 415.62 347.92 81.63 76.63 5.00
Respiratory spare capacity and the threshold value of inhibition of respiration derived from inhibitor titration of each the mitochondrial enzymes
examined. Spare capacity represents maximal uncoupled oxygen consumption during complete enzyme inhibition. Threshold values reﬂect total
inhibition of activity necessary before respiration is affected and the reduction of the threshold value represents the shift resulting from MAO-B
induction. The values are represented as % changes from uninhibited maximal uncoupled oxygen consumption
Table 2 Respiratory ﬂux control coefﬁcients
Enzyme Kd (inhibitor) Ci
Uninduced Induced Fold change
Aconitase Fluorocitrate 2.88 lM 0.0086 0.0180 2.10
aKGDH Arsenite 2.97 nM 0.0691 0.1120 1.62
aKGDH with (BrPy) Arsenite 2.97 nM 0.0777 0.7560 9.73
Complex I Rotenone 43.19 nM 0.3611 0.6457 1.79
SDH Malonate 34.33 lM 0.0763 0.0644 0.84
PDH Bromopyruvate 2.63 lM 0.0315 0.0295 0.94
KdðappÞ¼½ I =ððVo   ViÞ 1Þ; Ci ¼ð dJ=JÞ=ðdI=KdÞ
Respiratory ﬂux control by the individual mitochondrial enzymes examined in this study. The ﬂux control coefﬁcient of respiration (Ci)i s
derived as a function of the change in inhibition of enzyme activity and the corresponding change in respiration at that inhibition at the initial
stages of inhibition where dJ/J represents rate of change in respiration and dI/Kd represents the rate of change in inhibition. Kd is the apparent
inhibitor dissociation constant. These values are derived from the inhibitor titration curves of individual enzyme activities and initial points in the
substrate-speciﬁc respiration, as in Fig. 2 respectively
Neurotox Res (2009) 16:186–193 191
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assessed in terms of mitochondrial function without an
assessment of the relative control strengths of each com-
ponent (Harper et al. 1998).
In this study, we attempted to perform a limited MCA of
various enzymes affecting respiratory rates especially under
a condition ofincreased oxidativestressas a consequence of
MAO-B elevation. Generation of H2O2 via increased MAO-
B levels akin to that observed in aging and neurodegenera-
tive disease results in metabolic stress within the respiratory
apparatus by affecting components contributing to NADH
levels. Upon MAO-B induction, activity of all the enzymes
examineddiminishesandthemaximalrespirationwhichcan
be supported was found to be decreased. The spare capacity
and the respiratory threshold of each enzyme were found to
be reduced to varying degrees, near zero in the case of both
Complex I and KDGH under the high energy demand con-
ditions examined.
Under non-stress conditions, the sum of the control
coefﬁcients of all components examined is 0.6153, indicat-
ing that there are likely other contributors to metabolic
control in the uninduced cells. In the stress condition, the
sum of control coefﬁcients of all components examined
increases to 0.9473, indicating that the enzymes studied
have a large control over respiration in this situation.
Mitochondrial CI has been reported to be particularly sen-
sitive to oxidative stress and its inhibition hypothesized to
play a major role in mitochondrial dysfunction associated
with PD (Schapira et al. 1989; Mizuno et al. 1990; Lenaz
etal.1997).Wefoundthatitplaysamajorroleinoursystem
under both control and MAO-B induced conditions. The
spare capacity and threshold of inhibition of KDGH also
appears to be reduced to zero under the stress conditions
examined in this study. KGDH too has been reported to be
sensitive to damage by H2O2 and itself is a source of H2O2
when substrate-limited (Tretter and Adam-Vizi 2004; Star-
kov et al. 2004). Other mitochondrial enzymes are also
affected in our model but with less effect on their spare
capacitiesorinhibitionthresholds.PDHhasbeenreportedto
be impacted by H2O2 generated during ischemia (Bogaert
et al. 1994; Samikkannu et al. 2003; Tabatabaie et al. 1996).
Similarly, SDH has also been reported to be sensitive to
H2O2(Nulton-PerssonandSzweda2001;TretterandAdam-
Vizi 2000). Our data indicates that although all the enzymes
examined are inhibited under MAO-B induced stress, there
isavastdifferenceinthecontroltheyexertonmitochondrial
respiration. CI inhibition by MAO-B induced stress appears
to be more important than inhibition of the other enzymes
examined in this study suggesting that intervention to pre-
vent dopaminergic mitochondrial dysfunction should be
directed toward preservation of CI activity although KGDH
may also be of some import especially when its effects are
separated from PDH activity.
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